Paper33713223
Comparative Study of Wound-Healing Activity of Dihydroquercetin Pseudopolymorphic Modifications.
Terekhov RP and 9 others. Bull Exp Biol Med, 2021. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Comparative Study of Wound-Healing Activity of Dihydroquercetin Pseudopolymorphic Modifications. Papers, record 33713223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33713223
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative Study of Wound-Healing Activity of Dihydroquercetin Pseudopolymorphic Modifications.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Quercetin | Major topic |
| Wound Healing | Major topic |
| Animals | |
| Male | |
| Polymorphism, Genetic | |
| Rats | |
| Rats, Sprague-Dawley | |
| Regenerative Medicine |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30950819 | [Analysis of dihydroquercetin physical modification via in vitro and in silico methods]. | Biomed Khim | 2019 | https://conductscience.org/library/papers/30950819 | PubMed |
| 2 | 24694757 | Comparison of efficacy of topical phenytoin with hypericin in second-degree burn wound healing: an experimental study in rats. | Med Sci Monit Basic Res | 2014 | https://conductscience.org/library/papers/24694757 | PubMed |
| 3 | 25850419 | Toxicological and Genotoxicity Assessment of a Dihydroquercetin-Rich Dahurian Larch Tree (Larix gmelinii Rupr) Extract (Lavitol). | Int J Toxicol | 2015 | https://conductscience.org/library/papers/25850419 | PubMed |
| 4 | 19426789 | Nanodispersions of taxifolin: impact of solid-state properties on dissolution behavior. | Int J Pharm | 2009 | https://conductscience.org/library/papers/19426789 | PubMed |
| 5 | 27649117 | Detection of 191 Taxifolin Metabolites and Their Distribution in Rats Using HPLC-ESI-IT-TOF-MS(n). | Molecules | 2016 | https://conductscience.org/library/papers/27649117 | PubMed |
| 6 | 32455534 | Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32455534 | PubMed |
| 7 | 31081996 | Hyaluronic acid hydrogel loaded by adipose stem cells enhances wound healing by modulating IL-1β, TGF-β1, and bFGF in burn wound model in rat. | J Biomed Mater Res B Appl Biomater | 2020 | https://conductscience.org/library/papers/31081996 | PubMed |
| 8 | 31338467 | Cell cytotoxity and anti-glycation activity of taxifolin-rich extract from Japanese larch, Larix kaempferi. | Heliyon | 2019 | https://conductscience.org/library/papers/31338467 | PubMed |
| 9 | 28577102 | Dihydroquercetin Improves Microvascularization and Microcirculation in the Brain Cortex of SHR Rats during the Development of Arterial Hypertension. | Bull Exp Biol Med | 2017 | https://conductscience.org/library/papers/28577102 | PubMed |
| 10 | 17672120 | [Methods of determination of sizes of the wound surface]. | Vestn Khir Im I I Grek | 2007 | https://conductscience.org/library/papers/17672120 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41958938 | Exploring the therapeutic potential of naturally occurring taxifolin, a dietary flavonoid: an updated comprehensive review. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41958938 | PubMed |
| 41304920 | Dihydroquercetin in Weight Control: Systematic Review and Meta-Analysis of Preclinical Studies. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304920 | PubMed |
| 40144465 | Insights in wound healing properties of water-soluble composition of dihydroquercetin and L-lysine. | J Pharm Pharm Sci | 2025 | https://conductscience.org/library/papers/40144465 | PubMed |
| 37836832 | Research Progress of Dihydroquercetin in the Treatment of Skin Diseases. | Molecules | 2023 | https://conductscience.org/library/papers/37836832 | PubMed |
| 37569337 | Protective Properties of Spheroidal Taxifolin Form in Streptozotocin-Induced Diabetic Rats. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569337 | PubMed |
| 36837879 | LC-MS/MS and GC/MS Profiling of Petroselinum sativum Hoffm. and Its Topical Application on Burn Wound Healing and Related Analgesic Potential in Rats. | Metabolites | 2023 | https://conductscience.org/library/papers/36837879 | PubMed |
| 36555607 | Solubility Enhancement of Dihydroquercetin via "Green" Phase Modification. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555607 | PubMed |
| 35682702 | Insights into the Pharmacological Effects of Flavonoids: The Systematic Review of Computer Modeling. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682702 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33713223
GET https://conductscience.org/api/papers/v1/33713223/authors